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ABSTRACT
Purpose: The underlying causes of primary hypertension are not fully understood. Evidence on
the relation of plasma calcium concentration with blood pressure (BP) is inconsistent and relies
largely on studies utilizing office BP measurements in populations using cardiovascular drugs. In
many studies adjustment for confounders was not optimal. In this cross-sectional study we
examined the association of plasma total calcium concentration with the haemodynamic deter-
minants of blood pressure.
Subjects and methods: Supine haemodynamics were recorded using pulse wave analysis,
whole-body impedance cardiography, and heart rate variability analysis in 618 normotensive or
never-treated hypertensive subjects (aged 19–72 years) without diabetes, cardiovascular or renal
disease, or cardiovascular medications. Linear regression analysis was used to investigate factors
associated with haemodynamic variables.
Results: Mean age was 45.0 years, body mass index 26.8 kg/m2, seated office BP 141/89mmHg,
and 307 subjects (49.7%) were male. Mean values of routine blood and plasma chemistry analy-
ses were within the reference limits of the tests except for low-density lipoprotein cholesterol
(3.05mmol/l). In the laboratory, mean supine radial BP was 131/75mmHg, and both systolic and
diastolic BP correlated directly with plasma total calcium concentration (r¼ 0.25 and r¼ 0.22,
respectively, p< 0.001 for both). In regression analysis plasma total calcium concentration was
an independent explanatory variable for radial and aortic systolic and diastolic BP, and systemic
vascular resistance, but not for cardiac output, pulse wave velocity, or any of the heart rate vari-
ability parameters.
Conclusion: Plasma total calcium concentration was directly associated with systolic and diastolic
BP and systemic vascular resistance in normotensive or never-treated hypertensive subjects with-
out comorbidities and cardiovascular medications. Higher plasma calcium concentration poten-
tially plays a role in primary hypertension via an effect on vascular resistance.
ARTICLE HISTORY
Received 12 September 2019
Revised 17 October 2019
Accepted 11 November 2019
KEYWORDS
Plasma calcium; blood
pressure; systemic vascular
resistance; haemodynamics
Introduction
Despite the high global prevalence of hypertension
and its known clinical consequences, the underlying
causes of hypertension are still not fully understood.
In a vast majority of hypertensive subjects (90%)
the aetiology cannot be defined, and hence the term
primary hypertension is used [1,2]. The identification
of novel risk factors for hypertension is an important
step to better understand its aetiology, find novel
treatment targets, and reduce the associated burden of
morbidity and mortality.
Calcium and hormones regulating calcium balance
have been shown to be linked to the regulation of BP
[3–7] and risk of incident hypertension [8–10].
However, a comprehensive understanding of the relation
between calcium metabolism and BP remains to be
established. This is probably due to the complex nature
of calcium ion as an intracellular and extracellular mes-
senger [11,12], the complexity of calcium metabolism
with many interdependent hormones [13], the bidirec-
tional relationship between calcium metabolism and the
renin-angiotensin-aldosterone-system [14–17], and the
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putative direct functional role of the calcium-sensing
receptor (CaSR) in the vasculature [18–20].
Alterations in extracellular calcium levels may
influence calcium-mediated intracellular signalling
and potentially play a role in the pathogenesis of pri-
mary hypertension in humans [21]. However, serum
calcium concentration is tightly regulated by extracel-
lular CaSR in the parathyroid glands, and a concerted
interplay between the calcium regulating hormones
parathyroid hormone (PTH), vitamin D3 and to a
lesser extent calcitonin [12]. Studies that have exam-
ined the association between serum total calcium con-
centration and BP have yielded conflicting results
(Supplemental Table 1). Some studies reported a dir-
ect association, while others found no association.
Some of these studies were characterized by relatively
small sample sizes, and some by suboptimal adjust-
ment for confounders like smoking habits, alcohol
use, renal function, and plasma concentrations of
vitamin D metabolites and PTH. In addition, all
except two of the previous studies utilized office BP
measurements without detailed haemodynamic analy-
ses, and several investigations included subjects using
antihypertensive medications or other drugs with dir-
ect cardiovascular influences (Supplemental Table 1).
The inconsistent findings in the previous observa-
tions as well as the methodological questions pre-
sented above warrant further investigations of the
associations between calcium metabolism and haemo-
dynamics. We examined in a cross-sectional study
whether plasma total calcium concentration is associ-
ated with the haemodynamic determinants of BP in
618 normotensive or never-treated hypertensive sub-
jects without diabetes, cardiovascular or cerebrovascu-
lar disease, renal impairment, or medications with
direct cardiovascular influences. Haemodynamics
were characterized using pulse wave analysis, whole-
body impedance cardiography and heart rate variabil-
ity analysis.
Subjects and methods
Study population
This study is part of an ongoing research on haemo-
dynamics in primary and secondary hypertension (the
DYNAMIC-study, clinical trial registration
NCT01742702). The study complies with the
Declaration of Helsinki, and was approved by the eth-
ics committee of the Tampere University Hospital
(code R06086M) and the Finnish Medicines Agency
(Eudra-CT number 2006-002065-39). All methods
were carried out in accordance with the relevant
guidelines and regulations.
The present study subjects were screened from
1349 participants who were recruited via announce-
ments in local newspapers and in facilities of
Tampere University Hospital, University of Tampere,
Varala Sports Institute, and local organizations that
provide occupational health care. Signed informed
consent was obtained from all participants, and they
were interviewed and examined by a physician.
Smoking status was recorded and cigarette consump-
tion calculated as pack-years. Alcohol consumption
was recorded as standard drinks (12 grams of abso-
lute alcohol) per week. The use of medicines, dietary
supplements, and other substances not registered as
drugs was documented. Dairy product consumption
was recorded as standard daily doses. Seated office BP
was measured by a physician according to ESH/ESC
Guideline [22] using a manual sphygmomanometer
(Heine Gamma G7, Herrsching, Germany). The phase
I and V Korotkoff sounds were used to identify sys-
tolic and diastolic BP, respectively.
The exclusion criteria and number of subjects
excluded due to each reason were: 1) use of antihy-
pertensives or other medications with direct haemo-
dynamic influences (like a1-adrenoceptor blockers for
prostate hyperplasia, and b2-adrenoreceptor agonists
for asthma) (n¼ 619); 2) history of cardiovascular or
cerebrovascular disease (n¼ 176); 3) heart rhythm
other than sinus (n¼ 14); 4) diabetes mellitus
(n¼ 108); 5) chronic kidney disease [estimated glom-
erular filtration rate (GFR) <60ml/min/1.73 m2, or
proteinuria] (n¼ 73); 6) chronic liver disease (n¼ 0);
7) secondary hypertension [22] (n¼ 221); 8) psychi-
atric illness other than mild depression or anxiety
(n¼ 4); 9) alcohol or substance abuse (n¼ 23). No
recordings were performed for subjects with any acute
illness.
The study group consisted of 618 subjects (307
men and 311 women) aged 19–72 years. Based on the
office BP measurements, 248 (40.1%) of the partici-
pants were normotensive (95 men and 153 women)
and 370 (59.9%) were hypertensive (212 men and 158
women) [22]. In total 240 (38.9%) of the participants
used some medications. Seventy-six women used hor-
mones for contraception or hormone replacement
therapy, while 104 women were post-menopausal.
Thirteen subjects used statins, 1 took ezetimibe, 22
used thyroxin for hypothyroidism, 15 took inhaled
corticosteroids for asthma, 39 used antidepressants
(mainly selective serotonin reuptake inhibitors, while
5 subjects used amitriptyline, 4 subjects venlafaxine, 2
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subjects duloxetine, and 2 subjects mirtazapine), 6
were taking anxiolytics (benzodiazepines), and 2 sub-
jects used antiepileptics. Four subjects used COX-2
inhibitors and 5 subjects non-selective NSAIDs.
Laboratory analyses
Blood and urine samples were collected after 12 h
fasting. Plasma total calcium and other electrolytes,
cystatin C, creatinine, C-reactive protein (CRP), ala-
nine aminotransferase (ALT), alkaline phosphatase
(ALP), glucose, uric acid, and lipid determinations
were carried out using Cobas Integra 700/800 (F.
Hoffmann-LaRoche Ltd., Basel, Switzerland) or Cobas
6000, module c501 (Roche Diagnostics, Basel,
Switzerland). PTH and insulin were determined using
electrochemiluminescence immunoassay (Cobas e411,
Roche Diagnostics), and insulin sensitivity was eval-
uated by calculating quantitative insulin sensitivity
check index (QUICKI) [23]. Blood cell counts were
analysed using ADVIA 120 or 2120 (Bayer Health
Care, Tarrytown, NY, USA). Plasma renin activity
was measured using GammaCoat Plasma Renin
Activity assay (Diasorin S.p.A., Saluggia, Italy), and
aldosterone concentrations using active aldosterone
radioimmunoassay (Diagnostics Systems Laboratories,
Beckman Coulter, Webster, TX, USA). Plasma con-
centrations of calcidiol (25(OH)D3) and calcitriol
(1,25(OH)2D3) were analysed using enzyme immuno-
assay (Immunodiagnostic Systems, Boldon, UK).
Kidney disease was excluded by estimating GFR using
CKD-EPI cystatin C formula [24], and by urine dip-
stick analysis using an automated refractometer test
(Siemens Clinitec Atlas or Advantus, Siemens
Healthcare GmbH, Erlangen, Germany).
Protocol for haemodynamic measurements
Prior to the recordings the participants were
instructed to abstain from caffeine-containing prod-
ucts, smoking, and heavy meals for 4 h, and from
alcohol for 24 h. Haemodynamics were recorded in
a quiet temperature-controlled laboratory by a trained
nurse. The subjects rested supine for 10min, and
then the nurse measured BP twice by a manual
sphygmomanometer (Heine Gamma G7). Thereafter
beat-to-beat supine haemodynamic data was recorded
for 5min. The mean values of the variables during
the last 3min were used in the analyses, as this was
the most stable period. On average the data from
each subject represented 180 cardiac cycles. For the
heart rate variability analyses the mean values of the
whole 5-minute recording period were used.
Pulse wave analysis
Radial BP and pulse wave form were continuously
recorded using a tonometric sensor (Colin BP-508T,
Colin Medical Instruments Corp., San Antonio, TX,
USA) fixed on the left radial pulse. Radial BP meas-
urement was calibrated twice during the 5-minute
recording by contralateral brachial BP measurement
using an oschillometric cuff at the upper arm. Aortic
BP and pulse wave reflections were derived from the
tonometric signal with the SphygmoCorVR system
(SphygmoCorVR PWMx, AtCor Medical, Australia) uti-
lizing a validated transfer function [25]. Heart rate,
aortic pulse pressure, aortic augmentation pressure,
and augmentation index (AIx, aortic augmentation
pressure = aortic pulse pressure  100) were also
determined. AIx adjusted for heart rate of 75 beats/
min (AIx@75) was determined with the
SphygmoCorVR software.
Whole-body impedance cardiography
Whole-body impedance cardiography (CircMonVR
device, JR Medical Ltd., Estonia), which detects
changes in body’s electrical impedance during cardiac
cycles, was utilized to determine beat-to-beat heart
rate, stroke volume, cardiac output, aortic-to-popliteal
pulse wave velocity (PWV), extracellular water volume
(ECW), and ECW balance. The method and electrode
configuration have been described previously [26].
Finger BP was recorded using a plethysmographic cuff
(Finapres, Enschede, the Netherlands) in the left mid-
dle finger. Systemic vascular resistance (SVR) was cal-
culated from tonometric BP and cardiac output so that
the assumed normal central venous pressure (3mmHg)
was subtracted from mean arterial pressure and the
value was divided by cardiac output [26]. Cardiac out-
put, stroke volume and SVR were normalized for body
surface area to obtain cardiac index, stroke index and
SVR index.
ECW was evaluated with the CircMon device by
the formula ECW¼ k (height2/Z). The coefficient k
(X cm) is derived from blood resistivity and the
relation between the distance of voltage electrodes
and body height in centimeters, and Z is the recorded
impedance of the body. The ECW balance was calcu-
lated as ECW/ECWpredicted. The formula for ECWpredicted
was 2.4 (0.0236 height0.725weight0.423 1.229) in
males and 2.6(0.0248 height0.725weight0.423 1.9549)
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in females [27–29]. For easier interpretation, the results
of the ECW balance were adjusted so that the mean
value in the lowest calcium tertile was 1.0.
Stroke volume measured using CircMonVR corre-
lates well with values obtained with 3-dimensional
echocardiography [30]. Cardiac output measured with
CircMonVR correlates well with values measured with
the thermodilution and the direct oxygen Fick meth-
ods [26,31]. As the whole-body impedance cardiog-
raphy slightly overestimates PWV, a validated
equation (PWV¼ PWVimpedance 0.696þ 0.864) was
used to calculate values corresponding to Doppler
ultrasound method [32]. PWV values obtained using
this equation correlate well with values measured with
Doppler ultrasound or applanation tonometry [32,33].
Whole-body bioimpedance-derived ECW correlates
well with 51Cr-EDTA dilution-based measurement of
ECW (r¼ 0.74, bias 0.2 ± 1.1 litres), as well as with
perioperative weight changes of patients [34]. The
repeatability and reproducibility of this measurement
protocol has been previously established [32,35,36].
Frequency domain analysis of heart rate
variability
The electrocardiograms were recorded by the
CircMonVR device at sampling rate of 200Hz, and ana-
lysed using Matlab software (MathWorks Inc., Natick,
MA, USA). Normal R-R intervals were recognized,
and if the interval differed over 20% from the previ-
ous values the beat was considered as ectopic. The
artefacts were processed using the cubic spline inter-
polation method, and the frequency domain variables
were calculated using the Fast Fourier Transformation
method [37], consisting of 1) power in low frequency
(LF) range (0.04–0.15Hz), 2) power in high frequency
(HF) range (0.15–0.40Hz), and 3) LF/HF ratio. Both
LF and HF power were transformed to the natural
logarithm before analyses to yield normal non-skewed
distributions.
Statistical analyses
The subjects were divided into tertiles of plasma total
calcium concentration separately within each sex, and
the sex-specific tertiles were applied in the subsequent
analyses. The participants were also grouped accord-
ing to the use of calcium and/or vitamin D supple-
ments. One-way analysis of variance (ANOVA) was
applied to assess the differences in the clinical charac-
teristics, blood and plasma chemistry test values,
haemodynamic variables, and consumption of
supplements and dairy products. The Bonferroni cor-
rection was applied in the post-hoc analyses and
Levene’s test was used to test homogeneity
of variances.
Variables for linear regression analysis were
selected by utilizing Spearman’s nonparametric correl-
ation analysis for radial systolic and diastolic BP, and
p< 0.05 was used as the inclusion criterion. The nor-
mality of the distributions of the variables was
assessed using skewness and kurtosis data, and with
normal Q-Q plot, and with the Shapiro–Wilk test.
Due to skewed distributions, ECW balance, PTH,
1,25(OH)2D3, uric acid, CRP, triglycerides, high-
density lipoprotein (HDL) cholesterol, ALP, ALT, and
renin were corrected by Lg10-transformation. Smoking
status was categorized using two discrete variables
that enabled classification to current smokers, previ-
ous smokers or never smokers (category for smoking
or previous smoking was either 0 or 1, thus a never
smoker received a category 0 for both). Alcohol con-
sumption was categorized using three discrete varia-
bles (category either 0 or 1); cut-points for women 0
(abstinence), 1–7 (low consumption), 8–14 (moderate
consumption), and 15 doses per week (high con-
sumption); for men 0, 1–14, 15–24, and 25 doses
per week, respectively, according to the Finnish
Guidelines [38]. Linear regression analyses with back-
ward elimination were used to investigate explanatory
variables associated with the haemodynamic variables
of interest. The final regression model included age,
sex, body mass index (BMI), categorized alcohol con-
sumption, smoking status; use of dairy products, cal-
cium supplements, vitamin D supplements; QUICKI;
plasma concentrations of calcium, phosphate, sodium,
cystatin C, low-density lipoprotein (LDL) cholesterol;
and Lg10 of plasma concentrations of CRP, PTH,
1,25(OH)2D3, uric acid, ALP, ALT, triglycerides, HDL
cholesterol, renin; and Lg10 of ECW balance. In add-
itional analyses the subjects were divided into tertiles
according to age, and each tertile analysed separately.
SPSS version 25.0 for Windows software (IBM SPSS,
Armonk, NY, USA) was used for statistics. The results
are presented as mean with standard deviation (SD)
of the mean or with 95% confidence interval (CI) of
the mean, and p< 0.05 was considered statistically
significant.
Results
Study population
The total study population comprised of 618 subjects
and 49.7% (307) were men. Mean age was 45.0 years
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(range 19–72 years), mean BMI 26.8 kg/m2, and mean
seated office BP 141/89mmHg. Mean plasma total
calcium concentration was 2.28mmol/l (CI 2.27–2.30)
in women, and 2.32mmol/l (CI 2.31–2.33) in men
(p< 0.001). Therefore, the results below concerning
the tertiles of plasma calcium concentration were
adjusted for sex. The demographics and clinical char-
acteristics in each tertile of plasma total calcium con-
centration are presented in Table 1.
Mean age, BMI, ECW, percentage of current smok-
ers, dairy product consumption, and percentage of
calcium or vitamin D supplement users did not differ
between the calcium tertiles. Mean ECW balance was
lower in the highest calcium tertile versus the lowest
calcium tertile (0.97 vs. 1.00, respectively; p< 0.01).
Mean alcohol consumption as standard drinks per
week was somewhat higher in the highest calcium ter-
tile versus the lowest calcium tertile (5.4 vs. 3.7,
respectively; p< 0.05).
Mean values of blood and plasma chemistry test
results were within the reference limits of the tests in
all calcium tertiles, except for plasma total and LDL
cholesterol concentrations that were slightly above the
upper limits of the reference values in the middle and
highest tertiles (Supplemental Table 2). In addition to
the obvious deviations in mean plasma total calcium
concentration, there were small but statistically sig-
nificant (p< 0.05) differences in the mean plasma
chemistry test results between the calcium tertiles:
Plasma phosphate was higher in the highest calcium
tertile versus the other tertiles, while plasma
25(OH)D3 was higher in the highest calcium tertile
versus the lowest calcium tertile. Plasma cystatin C,
total and LDL cholesterol were higher, while esti-
mated GFR was lower, in the highest and the middle
calcium tertiles versus the lowest calcium tertile
(Supplemental Table 2).
In total 511 subjects used no calcium or vitamin D
supplements, while 6 subjects took calcium supple-
ments, 88 subjects took vitamin D supplements, and
13 subjects used both calcium and vitamin D supple-
ments (Supplemental Table 3). There were no differ-
ences between the groups in mean plasma total
calcium, phosphate or PTH concentrations, or in
dairy product consumption. However, mean
25(OH)D3 concentration was higher in the two
groups using vitamin D supplements when compared
with the group using neither calcium nor vitamin D
supplements (p< 0.05 for both). The plasma concen-
tration of 1,25(OH)2D3 was higher in the small group
(n¼ 13) taking both calcium and vitamin D supple-
ments when compared with the groups not taking the
supplements or using only vitamin D supplement
(p< 0.05 for both) (Supplemental Table 3).
BP and haemodynamic variables in the tertiles of
plasma total calcium concentration
Mean seated office BP did not differ between the cal-
cium tertiles (Table 1). However, mean supine systolic
BP was higher in the highest and the middle calcium
tertile versus the lowest calcium tertile when meas-
ured 1) at the brachial level indirectly by the research
nurse using the auscultatory method, 2) at the radial
Table 1. Demographics, clinical characteristics and laboratory results per tertile of plasma total calcium
concentration.
Demographics and clinical
characteristics Tertile 1 (n¼ 201) Tertile 2 (n¼ 218) Tertile 3 (n¼ 199)
Males (%) 49.3 53.2 48.2
Age (years) 44.9 (10.7) 45.8 (12.1) 44.4 (12.5)
Body mass index (kg/m2) 26.7 (4.4) 26.9 (4.3) 26.8 (4.3)
Extracellular water volume (l) 13.02 (1.75) 12.87 (1.90) 12.84 (1.90)
Extracellular water balance 1.00 (0.11) 0.98 (0.09) 0.97 (0.11)
Current smokers (%) 10.9 11.0 16.1
Alcohol consumption (standard
drinks/week)
3.7 (5.2) 4.4 (6.0) 5.4 (6.1)
Dairy product consumption
(standard dose/day)
3.0 (1.8) 3.0 (1.9) 3.4 (2.6)
Calcium supplement users (%) 1.5 2.3 5.5
Vitamin D supplement users (%) 11.9 17.0 20.1
Seated brachial office blood
pressure measured by
physician (mmHg)
139 (22)/88 (13) 142 (21)/90 (12) 142 (20)/90 (12)
Supine brachial blood pressure
measured by nurse (mmHg)
127 (17)/78 (12) 134 (20)/81 (12) 135 (18)/83 (11)
Supine radial laboratory blood
pressure (mmHg)
127 (19)/72 (12) 133 (20)/76 (13) 135 (19)/77 (13)
Supine finger laboratory blood
pressure (mmHg)
118 (17)/68 (12) 124 (19)/69 (13) 124 (20)/70 (13)
Results shown as mean (standard deviation). p< 0.05 vs. Tertile 1; p< 0.01 vs. Tertile 1.
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level using applanation tonometry, and 3) at the fin-
ger level using a plethysmographic cuff (p< 0.01 for
all, except for systolic finger BP p< 0.05) (Table 1).
Mean supine diastolic BP was also higher in the high-
est tertile versus the lowest tertile at the brachial level,
and in the highest and the middle calcium tertile ver-
sus the lowest calcium tertile at the radial level
(p< 0.01 for all) (Table 1).
Mean radial systolic and diastolic BPs were higher
in the middle and the highest calcium tertiles when
compared with the lowest calcium tertile (Figure
1(a,b)). Similarly, mean aortic systolic and diastolic
BPs were higher in the middle and the highest cal-
cium tertiles when compared with the lowest calcium
tertile (Supplemental Figure 1(a,b)).
Plasma total calcium concentration correlated posi-
tively with radial systolic and diastolic BP (r¼ 0.228,
and r¼ 0.195, respectively; p< 0.001 for both), aortic
systolic and diastolic BP (r¼ 0.199, and r¼ 0.194,
respectively; p< 0.001 for both), and finger systolic
and diastolic BP (r¼ 0.147, and r¼ 0.098; p< 0.001,
and p¼ 0.015, respectively), as well as with seated
office systolic and diastolic BP (r¼ 0.141, and
r¼ 0.129; p< 0.001, and p¼ 0.001, respectively).
Mean aortic pulse pressure was higher in the high-
est calcium tertile versus the lowest calcium tertile
(Figure 1(c)), while PVW was not different between
the calcium tertiles (Figure 1(d)). AIx, AIx@75, and
aortic augmentation pressure were not different
between the calcium tertiles (Supplemental Figure
1(c,d); AIx@75 not shown). Plasma total calcium con-
centration correlated with aortic pulse pressure
(r¼ 0.144, p< 0.001), but not with PVW, AIx,
AIx@75, or aortic augmentation pressure (r< 0.048,
p> 0.237 for all).
There were no statistically significant (p< 0.05) dif-
ferences between the calcium tertiles in mean heart
rate, stroke index, cardiac index, or SVR index
(Figure 2(a–d)). Plasma total calcium concentration
correlated with SVR index (r¼ 0.108, p¼ 0.007), but
not with heart rate, cardiac index, or stroke index
(r< 0.064, p> 0.113 for all). Also, no differences were
observed between calcium tertiles in the low-fre-
quency (LF) power, high-frequency (HF) power, and
LF/HF ratio of heart rate variability (Supplemental
Figure 2(a–c)). Plasma total calcium concentration
did not correlate with any of the heart rate variability
parameters (r< 0.069, p> 0.098 for all).
BP and haemodynamic variables in linear
regression analyses
Linear regression analyses showed that plasma total
calcium concentration was an independent explanatory
variable for radial systolic and diastolic BP (standar-
dized coefficient Beta ¼ 0.138, and 0.119; p¼ 0.001,
and p¼ 0.003, respectively) (Table 2). In additional
analyses plasma total calcium concentration was also
an independent explanatory variable for aortic systolic
and diastolic BP (Beta ¼ 0.149, and Beta ¼ 0.122;
p< 0.001, and p¼ 0.002, respectively), aortic pulse
pressure (Beta ¼ 0.120, p¼ 0.002), and for finger sys-
tolic BP (Beta ¼ 0.137, p¼ 0.001), but not for seated
Figure 1. Radial systolic blood pressure (a), radial diastolic
blood pressure (b), aortic pulse pressure (c), and pulse wave
velocity (d) in tertiles of plasma total calcium concentration
adjusted for sex; mean (circle) with 95% confidence intervals
of the mean (whiskers), one-way ANOVA with the Bonferroni
correction in post-hoc analyses.
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office systolic or diastolic BP (Beta ¼ 0.044, and Beta
¼ 0.052; p¼ 0.241, and p¼ 0.182, respectively).
As the major determinants of BP, the regression
analyses also examined cardiac output and SVR as the
variables of interest. Plasma total calcium concentra-
tion was not an explanatory variable for cardiac out-
put, but was an independent explanatory factor for
SVR (Beta ¼ 0.098, p¼ 0.029) (Table 3). Finally,
plasma total calcium concentration was not an inde-
pendent explanatory variable for PWV, AIx or AIx@75
(Beta¼0.007, Beta ¼ 0.047, and Beta ¼ 0.046;
p¼ 0.823, p¼ 0.145, and p¼ 0.137, respectively).
Additional analyses in tertiles of age
Although age did not correlate with plasma total cal-
cium concentration (r¼ 0.004, p¼ 0.923), additional
analyses were performed so that the subjects were
divided into tertiles of age. The age ranges in the
Tertiles 1, 2 and 3 were: 19.0–40.0, 40.1–52.0, and
52.1–72.0 years, with the mean (SD) ages of 31.1 (6.0),
46.8 (3.3), and 58.0 (4.1) years, respectively. When
each tertile was analysed separately using linear
regression analysis, plasma total calcium concentra-
tion was an independent explanatory variable for
radial systolic BP in all tertiles (Tertile 1 Beta ¼
0.203, p¼ 0.001; Tertile 2 Beta ¼ 0.151, p¼ 0.029;
and Tertile 3 Beta ¼ 0.265, p< 0.001), and for radial
diastolic BP in the middle and the highest tertile
(Tertile 1 Beta ¼ 0.117, p¼ 0.076; Tertile 2 Beta ¼
0.158, p¼ 0.023; and Tertile 3 Beta ¼ 0.246,
p¼ 0.001, respectively).
Discussion
In our study in 618 Caucasian normotensive or
never-treated hypertensive subjects, plasma total cal-
cium concentration was directly associated with radial
Figure 2. Heart rate (a), stroke index (b), cardiac index (c), and
systemic vascular resistance index (d) in tertiles of plasma total
calcium concentration adjusted for sex; mean (circle) with 95%
confidence intervals of the mean (whiskers), one-way ANOVA
with the Bonferroni correction in post-hoc analyses.
Table 2. Significant explanatory variables for radial systolic and diastolic blood pressure in linear regression analysis.
Systolic blood pressure (mmHg) B Beta p Diastolic blood pressure (mmHg) B Beta p
Model (R2¼ 0.320) Model (R2¼ 0.310)
(constant) 66.325 (constant) 9.582
Calcium 27.414 0.138 0.001 Cystatin C 16.029 0.181 <0.001
Cystatin C 18.017 0.137 0.002 LDL cholesterol 1.898 0.140 0.001
Age 0.222 0.135 0.002 PTH 12.181 0.139 <0.001
Body mass index 0.566 0.128 0.004 Age 0.147 0.133 0.003
LDL cholesterol 2.408 0.119 0.006 QUICKI 37.719 0.124 0.001
Sex (male) 4.319 0.112 0.005 Calcium 16.023 0.119 0.003
QUICKI 48.678 0.108 0.008 Phosphate 7.887 0.101 0.014
PTH 12.566 0.096 0.013 Sex (male) 2.312 0.089 0.025
Smoking (current) 4.917 0.085 0.022 Alcohol consumption (high) 6.619 0.078 0.034
Calcium supplement use 8.808 0.080 0.030 1,25(OH)2D3 7.212 0.076 0.047
LDL: low-density lipoprotein; QUICKI: quantitative insulin sensitivity check index; PTH: parathyroid hormone; 1,25(OH)2D3: 1,25-dihydroxyvitamin D3. Variables
in Model: Age, sex, body mass index, alcohol consumption (moderate, high), smoking status (current, previous), calcium, phosphate, Lg10 of PTH, Lg10 of
25(OH)D3, Lg10 of 1,25(OH)2D3, QUICKI, Lg10 of triglycerides, HDL cholesterol, LDL cholesterol, uric acid, alkaline phosphatase, alanine aminotransferase, sodium,
Lg10 of renin, Lg10 of C-reactive protein, cystatin C, calcium supplement use, vitamin D supplement use, and dairy products use (standard doses/day).
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and aortic systolic and diastolic BP, as well as sys-
temic vascular resistance, but not with cardiac output,
pulse wave velocity, or any of the heart rate variability
parameters. All participants were without previously
diagnosed diabetes, cardiovascular or cerebrovascular
disease, renal insufficiency, and medications with dir-
ect cardiovascular influences. The association of
plasma total calcium concentration with haemo-
dynamics was investigated using whole-body imped-
ance cardiography and analyses of pulse wave and
heart rate variability, and a comprehensive adjustment
for confounders was applied.
Our data indicates a direct association between
plasma total calcium concentration and central and
peripheral BP. Some previous reports observed a direct
relation between serum total calcium concentration
and seated office BP (Supplemental Table 1), while in
the present regression analyses plasma calcium con-
centration was not an explanatory factor for seated
office systolic and diastolic BP. Probably, the powerful
confounding by the white-coat effect interfered with
the BP measurements in the office [22], as statistically
significant (p< 0.05) differences in BP between the
present calcium tertiles were found in the laboratory
measurements performed by the research nurses using
the auscultatory, tonometric and plethysmographic
techniques. The observed direct association between
plasma total calcium concentration and BP was not
driven by age, as a direct association was present
when all age tertiles were analysed separately. These
findings indicate that plasma total calcium concentra-
tion should be considered as a potential contributor to
the pathophysiology of primary hypertension. The
observed differences in the supine systolic BP
(7mmHg) and diastolic BP (5mmHg) between the
highest and lowest calcium tertiles are also clinically
significant, as such a difference is associated with an
increased risk of cardiovascular disease [39,40].
Previously, Kim et al. [8] found that higher plasma
total calcium concentration (2.37 vs. <2.37mmol/l)
was associated with 1.24-fold increase in the incidence
of hypertension during 6 years of follow-up in a
Korean cohort of 5560 subjects.
The present regression analyses indicate that the
observed direct association between plasma total cal-
cium concentration and BP was mediated via SVR. In
most of the earlier studies, the haemodynamic com-
ponents involved in BP regulation were not addressed
(Supplemental Table 1). However, Schutte et al. [41]
investigated the associations of serum total calcium
concentration with 24-h ambulatory BP and
FinometerVR measurements during a stress test in 99
African men. They found that in younger men
(<43 years, n¼ 50), but not in older men, serum total
calcium concentration was directly associated with
24-h ambulatory BP and total peripheral resistance
during the stress test [41]. Previous experimental
studies have suggested that higher extracellular cal-
cium level increases calcium influx into arterial
smooth muscle, induces smooth muscle contraction,
and thus elevates SVR [4,42]. Experimental studies
have found that CaSR activation in vascular smooth
muscle sensitizes the arterial wall to contractile stim-
uli [20] and potentially influences the regulation of
SVR [43]. The CaSR is also expressed in the human
arterial wall [18]. Furthermore, acute calcium infusion
has been reported to impair endothelium-dependent
relaxation in healthy subjects [44], whereby extracellu-
lar calcium concentration may induce changes in
endothelium-mediated control of arterial tone that
contributes to the increase in SVR.
In the present study, plasma total calcium concen-
tration was not associated with PWV, wave reflection
(AIx), cardiac index, or ECW. Therefore, changes in
large arterial stiffness, cardiac output, or volume sta-
tus did not explain the higher BP associated with
higher plasma total calcium concentration. ECW bal-
ance was actually lowest in the highest calcium tertile.
Nevertheless, plasma total calcium concentration was
directly associated with aortic pulse pressure. This
finding can readily be attributed to higher vascular
resistance, as SVR has been shown to be one of the
major determinants of central pulse pressure in mid-
dle-aged subjects [45]. Recently Mateus-Hamdan et al.
[46] reported a direct association between plasma
total calcium concentration and supine brachial pulse
Table 3. Significant explanatory variables for cardiac output and systemic vascular resistance in linear regression analysis.
Cardiac output (ml/min) B Beta p Systemic vascular resistance (dynes s/cm5) B Beta p
Model (R2¼ 0.234) Model (R2¼ 0.146)
(constant) 5.231 (constant) 390
Sex (male) 0.946 0.403 <0.001 Sex (male) 152 0.253 <0.001
Body mass index 0.033 0.124 0.003 Age 5 0.195 <0.001
QUICKI 2.695 0.098 0.019 Vitamin D supplement use 91 0.111 0.010
Smoking (current) 0.332 0.094 0.014 LDL cholesterol 32 0.100 0.041
Calcium 306 0.098 0.029
Smoking (current) 80 0.088 0.042
QUICKI: quantitative insulin sensitivity check index; LDL: low-density lipoprotein. Variables in Model as in Table 2.
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pressure in 610 women aged 75 years, independently
of serum PTH and vitamin D levels. They discussed
that this direct association may be due to an increased
arterial stiffness and vascular calcification. However,
PWV or other variables reflecting large arterial stiff-
ness were not measured in that study [46].
We evaluated cardiac autonomic tone using analy-
ses of heart rate variability [47]. The 5-minute record-
ing was analysed by the frequency domain methods
according to the published standards [37]. The HF
oscillations of the recordings relate to parasympathetic
tone, whereas the LF fluctuations are mediated by
changes in both sympathetic and parasympathetic
tone [48]. The LF/HF ratio allows the evaluation of
the balance between these two components of the
autonomic nervous system [49]. We found no differ-
ences in the HF power, LF power, or LF/HF ratio
between the calcium tertiles. Also, plasma total cal-
cium concentration did not correlate with any of the
heart rate variability parameters. These results suggest
that the direct association of plasma total calcium
concentration with BP was not explained by changes
in autonomic tone. Comparable levels of heart rate,
cardiac output, plasma renin activity, and ECW across
the calcium tertiles support unchanged autonomic
tone, as these variables would be expected to increase
during activated sympathetic tone [50,51].
Plasma total calcium comprises of three major
forms: normally about 47% of the calcium is in the
biologically active free ionized form, 40% is bound to
serum proteins, mainly albumin, and the remaining
13% is complexed with anions such as bicarbonate,
phosphate, and lactate [52]. The determination of free
ionized calcium requires special sample handling and
carries higher risk of sources of error when compared
to plasma total calcium measurement [53]. Moreover,
plasma total calcium concentration is highly corre-
lated with ionized calcium concentration in patients
without serum protein or acid-base abnormalities
[53]. Plasma total calcium concentration is influenced
by the plasma albumin level. Numerous algorithms
have been developed to allow correction of plasma
total calcium concentration with the plasma albumin
level, but their reliability remains questionable
[54–56]. In the present study, we excluded partici-
pants with potential causes for abnormal plasma albu-
min concentration, like patients with renal disease,
diabetes, liver disease, or any severe acute or chronic
illness, and did not use albumin correction for the
plasma total calcium values.
Our study has limitations. Conclusions about
causal relationships are precluded by the cross-
sectional design. We cannot rule out a potential selec-
tion bias caused by the recruitment and exclusion
protocol. Some of the variables were different between
the lowest and highest plasma calcium tertiles, and
although these variables were adjusted for in the
regression analysis, they could have caused some
residual confounding. Also, we utilized indirect non-
invasive methods requiring mathematical processing
to derive stroke volume, cardiac output and PWV
from the bioimpedance signal [26], and central aortic
BP waveform from applanation tonometry signal [25],
and therefore the results must be interpreted with
caution, even though the methods have been validated
against direct or invasive measurements [30–32].
However, the approach to examine central haemo-
dynamics, rather than just to focus on brachial or
radial artery pressure, may be better related with the
level of cardiovascular risk [57,58]. We cannot exclude
increased renal sympathetic nerve activity as a cause for
elevated BP, as we only evaluated cardiac autonomic
tone by the use of heart rate variability analysis.
Nevertheless, normal plasma renin activity and ECW
support the view that renal sympathetic drive was not
altered. The heart rate variability data was filtered by
the use of a computer programme to exclude ectopic
beats, and unsatisfactory automatic filtering may have
exposed the data to potential errors [37]. Finally, we
cannot exclude potential multicollinearity problems that
were not controlled for by the statistical methods, as
some of the clinical characteristics and biochemical var-
iables are strongly correlated with each other.
To conclude, a direct association between plasma
total calcium concentration and supine systolic and dia-
stolic BP, and SVR was observed in 19- to 72-year-old
normotensive or never-treated hypertensive subjects
free of diabetes, cardiovascular or renal comorbidities,
and cardiovascular medications. Therefore, plasma cal-
cium concentration potentially plays a role in the
pathogenesis of primary hypertension via an effect on
vascular resistance. Prospective longitudinal studies are
needed to confirm the present finding.
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